Global Orally Administered Vaccine Market Research Report 2025(Status and Outlook)

March 2025 | 236 pages | ID: G49834BCF908EN
Bosson Research

Abstracts

Report Overview

Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection.

This report provides a deep insight into the global Orally Administered Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Orally Administered Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Orally Administered Vaccine market in any manner.

Global Orally Administered Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

GSK

Sanofi

Lanzhou Institute

Serum Institute

Valneva

Shanghai United Cell

Bibcol

PaxVax

Vabiotech

Tiantan Biological

EuBiologics

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Market Segmentation (by Type)

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Other

Market Segmentation (by Application)

Public

Private

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Orally Administered Vaccine Market
• Overview of the regional outlook of the Orally Administered Vaccine Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Orally Administered Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Orally Administered Vaccine
1.2 Key Market Segments
  1.2.1 Orally Administered Vaccine Segment by Type
  1.2.2 Orally Administered Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL ORALLY ADMINISTERED VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Orally Administered Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Orally Administered Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL ORALLY ADMINISTERED VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Orally Administered Vaccine Product Life Cycle
3.3 Global Orally Administered Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Orally Administered Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Orally Administered Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Orally Administered Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Orally Administered Vaccine Manufacturing Sites, Area Served, Product Type
3.8 Orally Administered Vaccine Market Competitive Situation and Trends
  3.8.1 Orally Administered Vaccine Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Orally Administered Vaccine Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 ORALLY ADMINISTERED VACCINE INDUSTRY CHAIN ANALYSIS

4.1 Orally Administered Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ORALLY ADMINISTERED VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Orally Administered Vaccine Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Orally Administered Vaccine Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL ORALLY ADMINISTERED VACCINE MARKET BY REGION

6.1 Global Orally Administered Vaccine Market Size by Region
  6.1.1 Global Orally Administered Vaccine Market Size by Region
  6.1.2 Global Orally Administered Vaccine Market Size Market Share by Region
6.2 Global Orally Administered Vaccine Sales by Region
  6.2.1 Global Orally Administered Vaccine Sales by Region
  6.2.2 Global Orally Administered Vaccine Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Orally Administered Vaccine Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Orally Administered Vaccine Market Size by Type
7.3 North America Orally Administered Vaccine Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Orally Administered Vaccine Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Orally Administered Vaccine Market Size by Type
8.3 Europe Orally Administered Vaccine Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Orally Administered Vaccine Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Orally Administered Vaccine Market Size by Type
9.3 Asia-Pacific Orally Administered Vaccine Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Orally Administered Vaccine Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Orally Administered Vaccine Market Size by Type
10.3 South America Orally Administered Vaccine Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Orally Administered Vaccine Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Orally Administered Vaccine Market Size by Type
11.3 Middle East and Africa Orally Administered Vaccine Market Size by Application

12 ORALLY ADMINISTERED VACCINE MARKET PRODUCTION BY REGION

12.1 Global Production of Orally Administered Vaccine by Region(2020-2025)
12.2 Global Orally Administered Vaccine Revenue Market Share by Region (2020-2025)
12.3 Global Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Orally Administered Vaccine Production
  12.4.1 North America Orally Administered Vaccine Production Growth Rate (2020-2025)
  12.4.2 North America Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Orally Administered Vaccine Production
  12.5.1 Europe Orally Administered Vaccine Production Growth Rate (2020-2025)
  12.5.2 Europe Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Orally Administered Vaccine Production (2020-2025)
  12.6.1 Japan Orally Administered Vaccine Production Growth Rate (2020-2025)
  12.6.2 Japan Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Orally Administered Vaccine Production (2020-2025)
  12.7.1 China Orally Administered Vaccine Production Growth Rate (2020-2025)
  12.7.2 China Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2020-2025)

13 ORALLY ADMINISTERED VACCINE MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Orally Administered Vaccine Sales Market Share by Type (2020-2033)
13.3 Global Orally Administered Vaccine Market Size Market Share by Type (2020-2033)
13.4 Global Orally Administered Vaccine Price by Type (2020-2033)

14 ORALLY ADMINISTERED VACCINE MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Orally Administered Vaccine Market Sales by Application (2020-2033)
14.3 Global Orally Administered Vaccine Market Size (M USD) by Application (2020-2033)
14.4 Global Orally Administered Vaccine Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Merck
  15.1.1 Merck Basic Information
  15.1.2 Merck Orally Administered Vaccine Product Overview
  15.1.3 Merck Orally Administered Vaccine Product Market Performance
  15.1.4 Merck Business Overview
  15.1.5 Merck SWOT Analysis
  15.1.6 Merck Recent Developments
15.2 GSK
  15.2.1 GSK Basic Information
  15.2.2 GSK Orally Administered Vaccine Product Overview
  15.2.3 GSK Orally Administered Vaccine Product Market Performance
  15.2.4 GSK Business Overview
  15.2.5 GSK SWOT Analysis
  15.2.6 GSK Recent Developments
15.3 Sanofi
  15.3.1 Sanofi Basic Information
  15.3.2 Sanofi Orally Administered Vaccine Product Overview
  15.3.3 Sanofi Orally Administered Vaccine Product Market Performance
  15.3.4 Sanofi Business Overview
  15.3.5 Sanofi SWOT Analysis
  15.3.6 Sanofi Recent Developments
15.4 Lanzhou Institute
  15.4.1 Lanzhou Institute Basic Information
  15.4.2 Lanzhou Institute Orally Administered Vaccine Product Overview
  15.4.3 Lanzhou Institute Orally Administered Vaccine Product Market Performance
  15.4.4 Lanzhou Institute Business Overview
  15.4.5 Lanzhou Institute Recent Developments
15.5 Serum Institute
  15.5.1 Serum Institute Basic Information
  15.5.2 Serum Institute Orally Administered Vaccine Product Overview
  15.5.3 Serum Institute Orally Administered Vaccine Product Market Performance
  15.5.4 Serum Institute Business Overview
  15.5.5 Serum Institute Recent Developments
15.6 Valneva
  15.6.1 Valneva Basic Information
  15.6.2 Valneva Orally Administered Vaccine Product Overview
  15.6.3 Valneva Orally Administered Vaccine Product Market Performance
  15.6.4 Valneva Business Overview
  15.6.5 Valneva Recent Developments
15.7 Shanghai United Cell
  15.7.1 Shanghai United Cell Basic Information
  15.7.2 Shanghai United Cell Orally Administered Vaccine Product Overview
  15.7.3 Shanghai United Cell Orally Administered Vaccine Product Market Performance
  15.7.4 Shanghai United Cell Business Overview
  15.7.5 Shanghai United Cell Recent Developments
15.8 Bibcol
  15.8.1 Bibcol Basic Information
  15.8.2 Bibcol Orally Administered Vaccine Product Overview
  15.8.3 Bibcol Orally Administered Vaccine Product Market Performance
  15.8.4 Bibcol Business Overview
  15.8.5 Bibcol Recent Developments
15.9 PaxVax
  15.9.1 PaxVax Basic Information
  15.9.2 PaxVax Orally Administered Vaccine Product Overview
  15.9.3 PaxVax Orally Administered Vaccine Product Market Performance
  15.9.4 PaxVax Business Overview
  15.9.5 PaxVax Recent Developments
15.10 Vabiotech
  15.10.1 Vabiotech Basic Information
  15.10.2 Vabiotech Orally Administered Vaccine Product Overview
  15.10.3 Vabiotech Orally Administered Vaccine Product Market Performance
  15.10.4 Vabiotech Business Overview
  15.10.5 Vabiotech Recent Developments
15.11 Tiantan Biological
  15.11.1 Tiantan Biological Basic Information
  15.11.2 Tiantan Biological Orally Administered Vaccine Product Overview
  15.11.3 Tiantan Biological Orally Administered Vaccine Product Market Performance
  15.11.4 Tiantan Biological Business Overview
  15.11.5 Tiantan Biological Recent Developments
15.12 EuBiologics
  15.12.1 EuBiologics Basic Information
  15.12.2 EuBiologics Orally Administered Vaccine Product Overview
  15.12.3 EuBiologics Orally Administered Vaccine Product Market Performance
  15.12.4 EuBiologics Business Overview
  15.12.5 EuBiologics Recent Developments
15.13 Panacea Biotec Ltd
  15.13.1 Panacea Biotec Ltd Basic Information
  15.13.2 Panacea Biotec Ltd Orally Administered Vaccine Product Overview
  15.13.3 Panacea Biotec Ltd Orally Administered Vaccine Product Market Performance
  15.13.4 Panacea Biotec Ltd Business Overview
  15.13.5 Panacea Biotec Ltd Recent Developments
15.14 Bio-Med
  15.14.1 Bio-Med Basic Information
  15.14.2 Bio-Med Orally Administered Vaccine Product Overview
  15.14.3 Bio-Med Orally Administered Vaccine Product Market Performance
  15.14.4 Bio-Med Business Overview
  15.14.5 Bio-Med Recent Developments
15.15 Halfkin Bio-Pharmaceuticals
  15.15.1 Halfkin Bio-Pharmaceuticals Basic Information
  15.15.2 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Overview
  15.15.3 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Market Performance
  15.15.4 Halfkin Bio-Pharmaceuticals Business Overview
  15.15.5 Halfkin Bio-Pharmaceuticals Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Orally Administered Vaccine Market Size by Type (M USD)
Table 4. Global Orally Administered Vaccine Market Size by Application (M USD)
Table 5. Orally Administered Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Orally Administered Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Orally Administered Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Orally Administered Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Orally Administered Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Administered Vaccine as of 2024)
Table 11. Global Market Orally Administered Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Orally Administered Vaccine Manufacturing Sites and Area Served
Table 13. Manufacturers Orally Administered Vaccine Product Type
Table 14. Global Orally Administered Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Orally Administered Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Orally Administered Vaccine Market Size Comparison by Region (M USD)
Table 26. Global Orally Administered Vaccine Market Size by Region (2020-2033) & (M USD)
Table 27. Global Orally Administered Vaccine Market Size Market Share by Region (2020-2033)
Table 28. Global Orally Administered Vaccine Sales by Region (2020-2033) & (K MT)
Table 29. Global Orally Administered Vaccine Sales Market Share by Region (2020-2033)
Table 30. North America Orally Administered Vaccine Market Size by Country (2020-2033) & (M USD)
Table 31. North America Orally Administered Vaccine Sales by Country (2020-2033) & (K MT)
Table 32. North America Orally Administered Vaccine Sales by Type (K MT)
Table 33. North America Orally Administered Vaccine Market Size by Type (M USD)
Table 34. North America Orally Administered Vaccine Sales (K MT) by Type (2020-2033)
Table 35. North America Orally Administered Vaccine Market Size (M USD) by Type (2020-2033)
Table 36. North America Orally Administered Vaccine Sales by Application (K MT)
Table 37. North America Orally Administered Vaccine Market Size by Application (M USD)
Table 38. North America Orally Administered Vaccine Sales (K MT) by Application (2020-2033)
Table 39. North America Orally Administered Vaccine Market Size (M USD) by Application (2020-2033)
Table 40. Europe Orally Administered Vaccine Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Orally Administered Vaccine Sales by Country (2020-2033) & (K MT)
Table 42. Europe Orally Administered Vaccine Sales by Type (K MT)
Table 43. Europe Orally Administered Vaccine Market Size by Type (M USD)
Table 44. Europe Orally Administered Vaccine Sales (K MT) by Type (2020-2033)
Table 45. Europe Orally Administered Vaccine Market Size (M USD) by Type (2020-2033)
Table 46. Europe Orally Administered Vaccine Sales by Application (K MT)
Table 47. Europe Orally Administered Vaccine Market Size by Application (M USD)
Table 48. Europe Orally Administered Vaccine Sales (K MT) by Application (2020-2033)
Table 49. Europe Orally Administered Vaccine Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Orally Administered Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Orally Administered Vaccine Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Orally Administered Vaccine Sales by Type (K MT)
Table 53. Asia-Pacific Orally Administered Vaccine Market Size by Type (M USD)
Table 54. Asia-Pacific Orally Administered Vaccine Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Orally Administered Vaccine Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Orally Administered Vaccine Sales by Application (K MT)
Table 57. Asia-Pacific Orally Administered Vaccine Market Size by Application (M USD)
Table 58. Asia-Pacific Orally Administered Vaccine Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Orally Administered Vaccine Market Size (M USD) by Application (2020-2025)
Table 60. South America Orally Administered Vaccine Market Size by Country (2020-2033) & (M USD)
Table 61. South America Orally Administered Vaccine Sales by Country (2020-2033) & (K MT)
Table 62. South America Orally Administered Vaccine Sales by Type (K MT)
Table 63. South America Orally Administered Vaccine Market Size by Type (M USD)
Table 64. South America Orally Administered Vaccine Sales (K MT) by Type (2020-2033)
Table 65. South America Orally Administered Vaccine Market Size (M USD) by Type (2020-2033)
Table 66. South America Orally Administered Vaccine Sales by Application (K MT)
Table 67. South America Orally Administered Vaccine Market Size by Application (M USD)
Table 68. South America Orally Administered Vaccine Sales (K MT) by Application (2020-2033)
Table 69. South America Orally Administered Vaccine Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Orally Administered Vaccine Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Orally Administered Vaccine Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Orally Administered Vaccine Sales by Type (K MT)
Table 73. Middle East and Africa Orally Administered Vaccine Market Size by Type (M USD)
Table 74. Middle East and Africa Orally Administered Vaccine Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Orally Administered Vaccine Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Orally Administered Vaccine Sales by Application (K MT)
Table 77. Middle East and Africa Orally Administered Vaccine Market Size by Application (M USD)
Table 78. Middle East and Africa Orally Administered Vaccine Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Orally Administered Vaccine Market Size (M USD) by Application (2020-2033)
Table 80. Global Orally Administered Vaccine Production (K MT) by Region(2020-2025)
Table 81. Global Orally Administered Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Orally Administered Vaccine Revenue Market Share by Region (2020-2025)
Table 83. Global Orally Administered Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Orally Administered Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Orally Administered Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Orally Administered Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Orally Administered Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Orally Administered Vaccine Sales by Type (K MT)
Table 89. Global Orally Administered Vaccine Market Size by Type (M USD)
Table 90. Global Orally Administered Vaccine Sales (K MT) by Type (2020-2033)
Table 91. Global Orally Administered Vaccine Sales Market Share by Type (2020-2033)
Table 92. Global Orally Administered Vaccine Market Size (M USD) by Type (2020-2033)
Table 93. Global Orally Administered Vaccine Market Size Share by Type (2020-2033)
Table 94. Global Orally Administered Vaccine Sales (K MT) by Application
Table 95. Global Orally Administered Vaccine Market Size by Application(M USD)
Table 96. Global Orally Administered Vaccine Sales by Application (2020-2033) & (K MT)
Table 97. Global Orally Administered Vaccine Sales Market Share by Application (2020-2033)
Table 98. Global Orally Administered Vaccine Market Size by Application (2020-2033) & (M USD)
Table 99. Global Orally Administered Vaccine Market Share by Application (2020-2033)
Table 100. Global Orally Administered Vaccine Sales Growth Rate by Application (2020-2033)
Table 101. Merck Basic Information
Table 102. Merck Orally Administered Vaccine Product Overview
Table 103. Merck Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Merck Business Overview
Table 105. Merck SWOT Analysis
Table 106. Merck Recent Developments
Table 107. GSK Basic Information
Table 108. GSK Orally Administered Vaccine Product Overview
Table 109. GSK Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. GSK Business Overview
Table 111. GSK SWOT Analysis
Table 112. GSK Recent Developments
Table 113. Sanofi Basic Information
Table 114. Sanofi Orally Administered Vaccine Product Overview
Table 115. Sanofi Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Sanofi Business Overview
Table 117. Sanofi SWOT Analysis
Table 118. Sanofi Recent Developments
Table 119. Lanzhou Institute Basic Information
Table 120. Lanzhou Institute Orally Administered Vaccine Product Overview
Table 121. Lanzhou Institute Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Lanzhou Institute Business Overview
Table 123. Lanzhou Institute Recent Developments
Table 124. Serum Institute Basic Information
Table 125. Serum Institute Orally Administered Vaccine Product Overview
Table 126. Serum Institute Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Serum Institute Business Overview
Table 128. Serum Institute Recent Developments
Table 129. Valneva Basic Information
Table 130. Valneva Orally Administered Vaccine Product Overview
Table 131. Valneva Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Valneva Business Overview
Table 133. Valneva Recent Developments
Table 134. Shanghai United Cell Basic Information
Table 135. Shanghai United Cell Orally Administered Vaccine Product Overview
Table 136. Shanghai United Cell Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Shanghai United Cell Business Overview
Table 138. Shanghai United Cell Recent Developments
Table 139. Bibcol Basic Information
Table 140. Bibcol Orally Administered Vaccine Product Overview
Table 141. Bibcol Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Bibcol Business Overview
Table 143. Bibcol Recent Developments
Table 144. PaxVax Basic Information
Table 145. PaxVax Orally Administered Vaccine Product Overview
Table 146. PaxVax Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. PaxVax Business Overview
Table 148. PaxVax Recent Developments
Table 149. Vabiotech Basic Information
Table 150. Vabiotech Orally Administered Vaccine Product Overview
Table 151. Vabiotech Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Vabiotech Business Overview
Table 153. Vabiotech Recent Developments
Table 154. Tiantan Biological Basic Information
Table 155. Tiantan Biological Orally Administered Vaccine Product Overview
Table 156. Tiantan Biological Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Tiantan Biological Business Overview
Table 158. Tiantan Biological Recent Developments
Table 159. EuBiologics Basic Information
Table 160. EuBiologics Orally Administered Vaccine Product Overview
Table 161. EuBiologics Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. EuBiologics Business Overview
Table 163. EuBiologics Recent Developments
Table 164. Panacea Biotec Ltd Basic Information
Table 165. Panacea Biotec Ltd Orally Administered Vaccine Product Overview
Table 166. Panacea Biotec Ltd Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Panacea Biotec Ltd Business Overview
Table 168. Panacea Biotec Ltd Recent Developments
Table 169. Bio-Med Basic Information
Table 170. Bio-Med Orally Administered Vaccine Product Overview
Table 171. Bio-Med Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Bio-Med Business Overview
Table 173. Bio-Med Recent Developments
Table 174. Halfkin Bio-Pharmaceuticals Basic Information
Table 175. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Overview
Table 176. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Halfkin Bio-Pharmaceuticals Business Overview
Table 178. Halfkin Bio-Pharmaceuticals Recent Developments
List of Figures
Figure 1. Product Picture of Orally Administered Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Orally Administered Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Orally Administered Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Orally Administered Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Orally Administered Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Orally Administered Vaccine Product Life Cycle
Figure 13. Orally Administered Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Orally Administered Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Orally Administered Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Orally Administered Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Orally Administered Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Orally Administered Vaccine
Figure 19. Global Orally Administered Vaccine Market PEST Analysis
Figure 20. Global Orally Administered Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Orally Administered Vaccine Market Size by Region
Figure 27. Global Orally Administered Vaccine Market Size Market Share by Region (2020-2033)
Figure 28. Global Orally Administered Vaccine Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Orally Administered Vaccine Market Size (M USD) by Country
Figure 33. USA Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Orally Administered Vaccine Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Orally Administered Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Orally Administered Vaccine Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Orally Administered Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Orally Administered Vaccine Market Size (M USD)by Type
Figure 40. North America Orally Administered Vaccine Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Orally Administered Vaccine Market Size (M USD) by Country
Figure 45. Germany Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Orally Administered Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Orally Administered Vaccine Market Size (M USD) by Type
Figure 56. Europe Orally Administered Vaccine Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Orally Administered Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Orally Administered Vaccine Market Size (M USD) by Country
Figure 61. China Orally Administered Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Orally Administered Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Orally Administered Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Orally Administered Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Orally Administered Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Orally Administered Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Orally Administered Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Orally Administered Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Orally Administered Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Orally Administered Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Orally Administered Vaccine Market Size (M USD) by Type
Figure 72. Asia-Pacific Orally Administered Vaccine Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Orally Administered Vaccine Market Size (M USD) by Country
Figure 77. Brazil Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Orally Administered Vaccine Market Size (M USD) by Type
Figure 84. South America Orally Administered Vaccine Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Orally Administered Vaccine Market Size (M USD) by Country
Figure 89. Saudi Arabia Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Orally Administered Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Orally Administered Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Orally Administered Vaccine Market Size (M USD) by Type
Figure 100. Middle East and Africa Orally Administered Vaccine Market Size (M USD) by Application
Figure 101. Global Orally Administered Vaccine Production Market Share by Region (2020-2025)
Figure 102. North America Orally Administered Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Orally Administered Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Orally Administered Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. China Orally Administered Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Orally Administered Vaccine Market Size by Type (M USD)
Figure 108. Sales Market Share of Orally Administered Vaccine by Type (2020-2033)
Figure 109. Sales Market Share of Orally Administered Vaccine by Type in 2024
Figure 110. Market Size Share of Orally Administered Vaccine by Type (2020-2033)
Figure 111. Market Size Share of Orally Administered Vaccine by Type in 2024
Figure 112. Global Orally Administered Vaccine Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Orally Administered Vaccine Market Size by Application(M USD)
Figure 115. Global Orally Administered Vaccine Market Share by Application
Figure 116. Global Orally Administered Vaccine Sales Market Share by Application (2020-2033)
Figure 117. Global Orally Administered Vaccine Sales Market Share by Application in 2024
Figure 118. Global Orally Administered Vaccine Market Share by Application (2020-2033)
Figure 119. Global Orally Administered Vaccine Market Share by Application in 2024
Figure 120. Global Orally Administered Vaccine Sales Growth Rate by Application (2020-2033)